Bio Works (Sweden) Today
| BIOWKS Stock | SEK 1.37 0.13 8.67% |
PerformanceGood
| Odds Of DistressAverage
|
Bio Works is trading at 1.37 as of the 25th of March 2025, a 8.67 percent decrease since the beginning of the trading day. The stock's open price was 1.5. Bio Works has 53 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. The performance scores are derived for the period starting the 25th of December 2024 and ending today, the 25th of March 2025. Click here to learn more.
Bio-Works Technologies AB researches, develops, manufactures, and supplies agarose based resins used to separate proteins and other biomolecules. Bio-Works Technologies AB founded in 2006 and is based in Uppsala, Sweden. Bio Works is traded on Stockholm Stock Exchange in Sweden. The company has 34.87 M outstanding shares. More on Bio Works Technologies AB
Moving together with Bio Stock
Moving against Bio Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bio Works' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio Works or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Biotechnology, Healthcare, Computing (View all Sectors) |
Bio Works Technologies AB (BIOWKS) is traded on Stockholm Exchange in Sweden and employs 36 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 718.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bio Works's market, we take the total number of its shares issued and multiply it by Bio Works's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bio Works Technologies operates under Healthcare sector and is part of Biotechnology industry. The entity has 34.87 M outstanding shares.
Bio Works Technologies AB has accumulated about 46.35 M in cash with (13.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Bio Works Probability Of Bankruptcy
Ownership AllocationBio Works holds a total of 34.87 Million outstanding shares. Bio Works Technologies AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bio Ownership Details
Bio Works Technologies Risk Profiles
Although Bio Works' alpha and beta are two of the key measurements used to evaluate Bio Works' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.9 | |||
| Semi Deviation | 3.85 | |||
| Standard Deviation | 5.26 | |||
| Variance | 27.64 |
Bio Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bio Works without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Bio Works Corporate Management
Elected by the shareholders, the Bio Works' board of directors comprises two types of representatives: Bio Works inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bio. The board's role is to monitor Bio Works' management team and ensure that shareholders' interests are well served. Bio Works' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bio Works' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sara Ekvall | Director Culture | Profile | |
| Anna Lindqvist | Chief Officer | Profile | |
| Jonathan Royce | Chief Officer | Profile | |
| David Nelander | Chief Officer | Profile | |
| Helena Pahlm | Director Quality | Profile | |
| Jan Berglf | CoFounder Advisor | Profile | |
| Karsten Fjrstedt | Chief Officer | Profile |
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.